Amgen Inc.
US ˙ NasdaqGS ˙ US0311621009

SecurityAMGN / Amgen Inc.
InstitutionMitchell Capital Management Co
Latest Disclosed Ownership712 shares
Latest Disclosed Value $ 250,517
Mitchell Capital Management Co ownership in AMGN / Amgen Inc.

On May 11, 2026 - Mitchell Capital Management Co filed a 13F-HR form disclosing ownership of 712 shares of Amgen Inc. (US:AMGN) valued at $250,517 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 712 shares of Amgen Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $240,813 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F Amgen COM 031162100 712 0 0.00 251 7.30 0.0460
2026-02-10 2025-12-31 13F Amgen COM 031162100 712 0 0.00 233 16.50 0.0417
2025-11-06 2025-09-30 13F Amgen COM 031162100 712 712 201 0.0344
2021-11-02 2021-09-30 13F Amgen COM 031162100 0 -14,174 -100.00 0 -100.00
2021-08-10 2021-06-30 13F Amgen COM 031162100 14,174 690 5.12 3,455 2.98 0.7582
2021-04-29 2021-03-31 13F Amgen COM 031162100 13,484 1,120 9.06 3,355 18.01 0.8187
2021-02-08 2020-12-31 13F Amgen COM 031162100 12,364 495 4.17 2,843 -5.77 0.7136
2020-11-10 2020-09-30 13F Amgen COM 031162100 11,869 356 3.09 3,017 11.12 0.8756
2020-07-29 2020-06-30 13F Amgen COM 031162100 11,513 75 0.66 2,715 17.08 0.8739
2020-05-06 2020-03-31 13F Amgen COM 031162100 11,438 1,621 16.51 2,319 -2.03 0.9042
2020-02-07 2019-12-31 13F Amgen COM 031162100 9,817 -155 -1.55 2,367 22.64 0.7523
2019-11-07 2019-09-30 13F Amgen COM 031162100 9,972 395 4.12 1,930 9.35 0.6521
2019-07-24 2019-06-30 13F Amgen COM 031162100 9,577 3,391 54.82 1,765 50.21 0.5918
2019-05-02 2019-03-31 13F Amgen COM 031162100 6,186 -829 -11.82 1,175 -13.98 0.4152
2019-02-08 2018-12-31 13F Amgen COM 031162100 7,015 887 14.47 1,366 7.56 0.5773
2018-11-08 2018-09-30 13F Amgen COM 031162100 6,128 630 11.46 1,270 25.12 0.4124
2018-08-10 2018-06-30 13F Amgen COM 031162100 5,498 3,627 193.85 1,015 218.18 0.3665
2018-05-04 2018-03-31 13F Amgen COM 031162100 1,871 1,871 319 0.1153
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.